TLRY vs. CRON, WEED, GUD, BHC, DNTL, SIA, WELL, EXE, ACB, and OGI
Should you be buying Tilray Brands stock or one of its competitors? The main competitors of Tilray Brands include Cronos Group (CRON), Canopy Growth (WEED), Knight Therapeutics (GUD), Bausch Health Companies (BHC), dentalcorp (DNTL), Sienna Senior Living (SIA), WELL Health Technologies (WELL), Extendicare (EXE), Aurora Cannabis (ACB), and Organigram (OGI). These companies are all part of the "medical" sector.
Tilray Brands (TSE:TLRY) and Cronos Group (TSE:CRON) are both medical companies, but which is the superior business? We will compare the two companies based on the strength of their dividends, risk, analyst recommendations, profitability, earnings, community ranking, media sentiment, institutional ownership and valuation.
10.5% of Tilray Brands shares are owned by institutional investors. Comparatively, 13.1% of Cronos Group shares are owned by institutional investors. 1.3% of Tilray Brands shares are owned by company insiders. Comparatively, 46.6% of Cronos Group shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term.
Tilray Brands has a beta of 2.38, meaning that its stock price is 138% more volatile than the S&P 500. Comparatively, Cronos Group has a beta of 1.12, meaning that its stock price is 12% more volatile than the S&P 500.
Cronos Group received 69 more outperform votes than Tilray Brands when rated by MarketBeat users. Likewise, 51.11% of users gave Cronos Group an outperform vote while only 0.00% of users gave Tilray Brands an outperform vote.
In the previous week, Cronos Group had 3 more articles in the media than Tilray Brands. MarketBeat recorded 3 mentions for Cronos Group and 0 mentions for Tilray Brands. Cronos Group's average media sentiment score of 0.76 beat Tilray Brands' score of 0.00 indicating that Cronos Group is being referred to more favorably in the news media.
Tilray Brands currently has a consensus price target of C$2.95, indicating a potential upside of 11.32%. Cronos Group has a consensus price target of C$2.77, indicating a potential downside of 27.11%. Given Tilray Brands' higher possible upside, analysts clearly believe Tilray Brands is more favorable than Cronos Group.
Cronos Group has lower revenue, but higher earnings than Tilray Brands. Cronos Group is trading at a lower price-to-earnings ratio than Tilray Brands, indicating that it is currently the more affordable of the two stocks.
Tilray Brands has a net margin of -47.35% compared to Cronos Group's net margin of -84.78%. Cronos Group's return on equity of -6.30% beat Tilray Brands' return on equity.
Summary
Cronos Group beats Tilray Brands on 10 of the 16 factors compared between the two stocks.
Get Tilray Brands News Delivered to You Automatically
Sign up to receive the latest news and ratings for TLRY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding TLRY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of TSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Tilray Brands Competitors List
Related Companies and Tools
